Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation

Immunization with the conjugated quadrivalent (serogroups A, C, Y, and W-135) meningococcal vaccine (MCV4) after hematopoietic cell transplantation (HCT) is recommended. However, immune responses to MCV4 have not been prospectively studied after HCT. We conducted a vaccine response study among 67 ad...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood Adv
Hlavní autoři: Cheng, Matthew P., Pandit, Alisha, Antin, Joseph H., Walsh, Stephen R., Huynh, Daisy, Ghobrial, Irene M., Baden, Lindsey R., Marty, Francisco M., Issa, Nicolas C.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2018
Témata:
Clinical Trials and Observations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5998919/
https://ncbi.nlm.nih.gov/pubmed/29871892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018018911
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky